Scientists at Gladstone Institutes have linked various neurological diseases to blood leakage into the brain, sparking harmful immune reactions. Research has shown that neutralizing the blood protein fibrin can prevent these effects and is protective in animal models. A novel fibrin-targeting immunotherapy is undergoing Phase 1 clinical trials, promising new treatments for diseases like Alzheimer’s and multiple sclerosis.